Literature DB >> 33945504

Is complement the culprit behind COVID-19 vaccine-related adverse reactions?

Dimitrios C Mastellos1, Panagiotis Skendros2, John D Lambris3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33945504      PMCID： PMC8159677          DOI： 10.1172/JCI151092

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   19.456


× No keyword cloud information.
  22 in total

1.  Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk.

Authors:  Meike Heurich; Ruben Martínez-Barricarte; Nigel J Francis; Dawn L Roberts; Santiago Rodríguez de Córdoba; B Paul Morgan; Claire L Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 2.  Complementopathies and precision medicine.

Authors:  Eleni Gavriilaki; Robert A Brodsky
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

3.  Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.

Authors:  Reinhard J Sauter; Manuela Sauter; Edimara S Reis; Frederic N Emschermann; Henry Nording; Sonja Ebenhöch; Peter Kraft; Patrick Münzer; Maximilian Mauler; Johannes Rheinlaender; Johannes Madlung; Frank Edlich; Tilman E Schäffer; Sven G Meuth; Daniel Duerschmied; Tobias Geisler; Oliver Borst; Meinrad Gawaz; Christoph Kleinschnitz; John D Lambris; Harald F Langer
Journal:  Circulation       Date:  2018-10-16       Impact factor: 29.690

4.  Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.

Authors:  Peter Hillmen; Jeff Szer; Ilene Weitz; Alexander Röth; Britta Höchsmann; Jens Panse; Kensuke Usuki; Morag Griffin; Jean-Jacques Kiladjian; Carlos de Castro; Hisakazu Nishimori; Lisa Tan; Mohamed Hamdani; Pascal Deschatelets; Cedric Francois; Federico Grossi; Temitayo Ajayi; Antonio Risitano; Régis Peffault de la Tour
Journal:  N Engl J Med       Date:  2021-03-18       Impact factor: 91.245

5.  Complement C5 but not C3 is expendable for tissue factor activation by cofactor-independent antiphospholipid antibodies.

Authors:  Nadine Müller-Calleja; Svenja Ritter; Anne Hollerbach; Tanja Falter; Karl J Lackner; Wolfram Ruf
Journal:  Blood Adv       Date:  2018-05-08

6.  Complement as a target in COVID-19?

Authors:  Antonio M Risitano; Dimitrios C Mastellos; Markus Huber-Lang; Despina Yancopoulou; Cecilia Garlanda; Fabio Ciceri; John D Lambris
Journal:  Nat Rev Immunol       Date:  2020-04-23       Impact factor: 53.106

7.  Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathy.

Authors:  Mahima Kapoor; Jennifer Spillane; Christina Englezou; Scherezade Sarri-Gonzalez; Robert Bell; Alexander Rossor; Hadi Manji; Mary M Reilly; Michael P Lunn; Aisling Carr
Journal:  Neurology       Date:  2019-12-18       Impact factor: 9.910

Review 8.  Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.

Authors:  Matteo Marchetti; Maxime G Zermatten; Debora Bertaggia Calderara; Alessandro Aliotta; Lorenzo Alberio
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

9.  Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination.

Authors:  Kate-Lynn Muir; Avyakta Kallam; Scott A Koepsell; Krishna Gundabolu
Journal:  N Engl J Med       Date:  2021-04-14       Impact factor: 91.245

10.  Prothrombotic immune thrombocytopenia after COVID-19 vaccination.

Authors:  Andreas Tiede; Ulrich J Sachs; Andreas Czwalinna; Sonja Werwitzke; Rolf Bikker; Joachim K Krauss; Frank Donnerstag; Karin Weißenborn; Günter Höglinger; Benjamin Maasoumy; Heiner Wedemeyer; Arnold Ganser
Journal:  Blood       Date:  2021-07-29       Impact factor: 25.476
View more
  7 in total

1.  Antiplatelet drugs block platelet activation by VITT patient serum.

Authors:  Christopher W Smith; Samantha J Montague; Caroline Kardeby; Ying Di; Gillian C Lowe; William A Lester; Steve P Watson; Phillip L R Nicolson
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476

Review 2.  Scientific premise for the involvement of neutrophil extracellular traps (NETs) in vaccine-induced thrombotic thrombocytopenia (VITT).

Authors:  Junaid Kashir; Ayesha Rahman Ambia; Areez Shafqat; Muhammad Raihan Sajid; Khaled AlKattan; Ahmed Yaqinuddin
Journal:  J Leukoc Biol       Date:  2021-09-01       Impact factor: 6.011

3.  Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination.

Authors:  Jonathan Douxfils; Julien Favresse; Jean-Michel Dogné; Thomas Lecompte; Sophie Susen; Charlotte Cordonnier; Aurélien Lebreton; Robert Gosselin; Pierre Sié; Gilles Pernod; Yves Gruel; Philippe Nguyen; Caroline Vayne; François Mullier
Journal:  Thromb Res       Date:  2021-05-15       Impact factor: 3.944

Review 4.  COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review.

Authors:  Malay Sarkar; Irappa V Madabhavi; Pham Nguyen Quy; Manjunath B Govindagoudar
Journal:  Ann Thorac Med       Date:  2022-01-14       Impact factor: 2.219

5.  Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects.

Authors:  Rima Hajjo; Dima A Sabbah; Alexander Tropsha
Journal:  Pathogens       Date:  2022-06-29

6.  Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes.

Authors:  Sanjay Khandelwal; Ayiesha Barnes; Lubica Rauova; Amrita Sarkar; Ann H Rux; Serge V Yarovoi; S Sergei Zaitsev; John D Lambris; Sooho S Myoung; Alexandra Johnson; Grace M Lee; Madelaine Duarte; Mortimer Poncz; Gowthami M Arepally; Douglas B Cines
Journal:  Blood       Date:  2021-11-25       Impact factor: 22.113

7.  SVM Communications: Vaccine-induced immune thrombotic thrombocytopenia (VITT) - what the vascular medicine physician should know.

Authors:  Leben Tefera; Scott J Cameron
Journal:  Vasc Med       Date:  2021-07-18       Impact factor: 3.239
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.